Literature DB >> 9106476

DCG-IV, a potent metabotropic glutamate receptor agonist, as an NMDA receptor agonist in the rat cortical slice.

Y Uyama1, M Ishida, H Shinozaki.   

Abstract

The depolarization induced by DCG-IV, a potent agonist for Group II metabotropic glutamate receptors (Group II mGluRs), was depressed by selective antagonists for NMDA receptors in the rat cortical slice, but was not affected even by a high concentration of a selective antagonist for Group II mGluRs. DCG-IV caused depolarization more effective than NMDA in a dose-dependent manner with a threshold concentration of 3 microM in rat cortical slices, while DCG-IV was less active than NMDA in rat spinal cords. These actions should be carefully considered particularly when DCG-IV is used as an agonist for mGluRs in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9106476     DOI: 10.1016/s0006-8993(97)00079-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Role of group II and III metabotropic glutamate receptors in rhythmic patterns of the neonatal rat spinal cord in vitro.

Authors:  Giuliano Taccola; Cristina Marchetti; Andrea Nistri
Journal:  Exp Brain Res       Date:  2004-03-09       Impact factor: 1.972

2.  N-methyl-D-aspartate receptors and large conductance calcium-sensitive potassium channels inhibit the release of opioid peptides that induce mu-opioid receptor internalization in the rat spinal cord.

Authors:  B Song; J C G Marvizón
Journal:  Neuroscience       Date:  2005-10-03       Impact factor: 3.590

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  Involvement of metabotropic glutamate receptors in ischemia-induced taurine release in the developing and adult hippocampus.

Authors:  P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  2000-08       Impact factor: 3.996

5.  The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndrome.

Authors:  Jesse E Hanson; Martina Blank; Ricardo A Valenzuela; Craig C Garner; Daniel V Madison
Journal:  J Physiol       Date:  2006-12-07       Impact factor: 5.182

6.  Mechanisms of adenosine release in the developing and adult mouse hippocampus.

Authors:  Pirjo Saransaari; Simo S Oja
Journal:  Neurochem Res       Date:  2002-09       Impact factor: 3.996

Review 7.  Chimeric Structures in Mental Illnesses-"Magic" Molecules Specified for Complex Disorders.

Authors:  Patrycja Kleczkowska
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

Review 8.  The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies.

Authors:  Rebecca K Senter; Ayan Ghoshal; Adam G Walker; Zixiu Xiang; Colleen M Niswender; P Jeffrey Conn
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.